As the stabilization period for the Drug Supply Chain Security Act (DSCSA) continues, a critical focus is on handling problems and exceptions that occur when the digital and physical information about pharmaceutical products do not match. These errors cause disruption, leading to an “unhappy path” for product flow and stalls in the supply chain. How might manufacturers, wholesalers, dispensers and other stakeholders navigate this? Hear from a major health system and their partners on efforts to implement the latest GS1 recommendations for correcting these errors – getting them one step closer to a happier, and healthier, supply chain.